A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Viatris Inc stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 599 shares of VTRS stock, worth $7,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
599
Previous 159 276.73%
Holding current value
$7,787
Previous $1,000 500.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$10.32 - $12.13 $4,540 - $5,337
440 Added 276.73%
599 $6,000
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $15,647 - $18,715
-1,557 Reduced 90.73%
159 $1,000
Q1 2024

Apr 30, 2024

BUY
$11.27 - $13.53 $9,004 - $10,810
799 Added 87.13%
1,716 $20,000
Q4 2023

Jan 30, 2024

SELL
$8.77 - $10.85 $7,568 - $9,363
-863 Reduced 48.48%
917 $9,000
Q2 2023

Jul 19, 2023

SELL
$9.02 - $10.29 $414 - $473
-46 Reduced 2.52%
1,780 $17,000
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $6,844 - $9,121
744 Added 68.76%
1,826 $17,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $784 - $1,040
-90 Reduced 7.68%
1,082 $12,000
Q3 2022

Oct 26, 2022

SELL
$8.48 - $11.13 $474 - $623
-56 Reduced 4.56%
1,172 $9,000
Q2 2022

Aug 10, 2022

SELL
$9.95 - $12.27 $5,333 - $6,576
-536 Reduced 30.39%
1,228 $12,000
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $2,344 - $3,680
239 Added 15.67%
1,764 $19,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $3,119 - $3,787
-258 Reduced 14.47%
1,525 $20,000
Q3 2021

Nov 02, 2021

SELL
$13.25 - $15.13 $92 - $105
-7 Reduced 0.39%
1,783 $24,000
Q2 2021

Jul 27, 2021

SELL
$12.97 - $16.15 $428 - $532
-33 Reduced 1.81%
1,790 $25,000
Q1 2021

May 11, 2021

BUY
$13.59 - $18.54 $24,774 - $33,798
1,823 New
1,823 $25,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.